For more than a week the internet has been inundated with award show drama. During the 93rd Academy ceremony, comedian Chris Rock lightheartedly joked about Jaida Smith’s shaved head being reminiscent of G.I. Jane. Her husband Will angrily marched on stage and violently slapped the host. Viewers are torn on the authenticity of this televised episode. Some insist the assault was genuine while others believe it’s merely a staged performance to boost formerly plummeting ratings. However, what cannot be debated is the ensuing media frenzy. Seemingly overnight there is constant discussion and rampant news coverage of a particular autoimmune disease called alopecia areata. The headlining actress suffers from this condition which causes hair loss. In an interesting twist, Oscars-sponsor Pfizer just so happens to be finalizing a new drug that treats—you guessed it: alopecia. 
Brought to You by Big Pharma
Hollywood has a dark track record filled with unbridled pedophilia, ritualistic abuse, and pushing an insidious agenda. Amid the pandemic-era celebrities have become Big Pharma’s most outspoken proponents. Pfizer and Eli Lilly representatives recently paid millions of dollars to broadcast the annual star-studded gala. Simultaneously, the multinational biotechnology company is completing Phase 3 clinical trials using a rheumatoid arthritis medication to treat alopecia. Baricitinib, a Janus kinase (JAK) inhibitor, is said to be effective in combating the disfiguring skin ailment. Soon these patented cytokine-restricting pills will be presented to the Federal Food & Drug Administration for additional review and approval. Cue the Oscars’ supposedly ‘random’ attention-grabbing incident. What better marketing campaign than bombarding potential consumers with information about the disorder your product claims to cure?
